Conditions Resulting from Claritin
User-reported conditions resulting from Claritin based on their intuition.
| Resulting Condition | Agree |
|---|---|
| Dry Mouth | 7% |
Treatment Effectiveness
User reported effectiveness ratings Claritin for various conditions.
| Conditions | Major Improvement | Moderate Improvement | Much Worse | No Effect | Worse | Responses |
|---|---|---|---|---|---|---|
| Allergies | 13% | 45% | 3% | 34% | 5% | 638 |
| Throat Clearing | 0% | 27% | 5% | 59% | 9% | 22 |
Side Effects
User-reported side effects of Claritin
| Side Effect | Percent of Reports Claritin |
|---|---|
| Nervousness | 13% |
| Diarrhea | 4% |
| Dry Mouth | 30% |
| Stomach Pain | 6% |
| Bitter Taste in Mouth | 6% |
| Bronchitus | 0% |
| Crazy Dreams | 8% |
| Difficulty Falling Asleep or Staying Asleep | 20% |
| Drowsiness | 16% |
| Mouth Sores | 3% |
| Nosebleed | 7% |
| Palpitations | 11% |
| Panic Attack | 0% |
| Rapid Heartbeat | 11% |
| Red or Itchy Eyes | 9% |
| Runny Nose | 10% |
| Sneezing | 7% |
| Sore Throat | 8% |
| Weakness | 7% |
| Anxiety / Nervousness | 22% |
| Headache | 14% |
Outcomes
Below is the degree of change seen after Claritin is higher than average.
|
|
Don't see what you're looking for?
Create a study and help us eradicate suffering!
Daily Distribution
Average by Year
Average by Month
Average by Day of Week
Outcomes Label
Claritin Info
| Property | Value |
|---|---|
| Variable Name | Claritin |
| Aggregation Method | SUM |
| Analysis Performed At | 2020-10-08 |
| Duration of Action | 21 days |
| Filling Value | 0 |
| Mean | 25 count |
| Median | 25 count |
| Minimum Allowed Value | 0 count |
| Number of Aggregate Predictors | 0 |
| Number of Aggregate Outcomes | 0 |
| Number of Measurements | 1 |
| Number of Measurements (including those generated by tagged, joined, or child variables) | 1 |
| Public | true |
| Onset Delay | 30 minutes |
| Standard Deviation | 0 |
| Unit | Count |
| User Variables | 4 |
| UPC | 041100805119 |
| Variable Category | Treatments |
| Variable ID | 92920 |
| Variance | 0 |